Novelix Pharmaceuticals Ltd (NOVE)

Currency in INR
49.80
+2.35(+4.95%)
Delayed Data·
NOVE Scorecard
Full Analysis
Quickly burning through cash
Unusual trading volume
NOVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
46.0149.80
52 wk Range
21.9152.79
Key Statistics
Bid/Ask
49.00 / 49.80
Prev. Close
47.45
Open
48
Day's Range
46.01-49.8
52 wk Range
21.91-52.79
Volume
15.2K
Average Volume (3m)
6.33K
1-Year Change
116.57%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NOVE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Novelix Pharmaceuticals Ltd Company Profile

Novelix Pharmaceuticals Limited trades in pharmaceuticals and related products in India. It also trades in shares and securities; retails pharmaceuticals; and offers marketing services. The company was formerly known as Trimurthi Limited and changed its name to Novelix Pharmaceuticals Limited in October 2024. Novelix Pharmaceuticals Limited was incorporated in 1994 and is based in Hyderabad, India.

Compare NOVE to Peers and Sector

Metrics to compare
NOVE
Peers
Sector
Relationship
P/E Ratio
126.0x25.8x−0.7x
PEG Ratio
0.310.140.00
Price/Book
3.9x4.3x2.6x
Price / LTM Sales
1.3x4.5x3.4x
Upside (Analyst Target)
-16.2%37.7%
Fair Value Upside
Unlock−5.4%5.0%Unlock

Earnings

Latest Release
Aug 14, 2025
EPS / Forecast
0.09 / --
Revenue / Forecast
223.51M / --
EPS Revisions
Last 90 days

NOVE Income Statement

FAQ

What Stock Exchange Does Novelix Pharmaceuticals Trade On?

Novelix Pharmaceuticals is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Novelix Pharmaceuticals?

The stock symbol for Novelix Pharmaceuticals is "NOVE."

What Is the Novelix Pharmaceuticals Market Cap?

As of today, Novelix Pharmaceuticals market cap is 721.10M.

What Is Novelix Pharmaceuticals's Earnings Per Share (TTM)?

The Novelix Pharmaceuticals EPS (TTM) is 0.50.

From a Technical Analysis Perspective, Is NOVE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Novelix Pharmaceuticals Stock Split?

Novelix Pharmaceuticals has split 2 times.

How Many Employees Does Novelix Pharmaceuticals Have?

Novelix Pharmaceuticals has 8 employees.

What is the current trading status of Novelix Pharmaceuticals (NOVE)?

As of 27 Oct 2025, Novelix Pharmaceuticals (NOVE) is trading at a price of 49.80, with a previous close of 47.45. The stock has fluctuated within a day range of 46.01 to 49.80, while its 52-week range spans from 21.91 to 52.79.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.